Savara, Inc.Savara, Inc.Savara, Inc.

Savara, Inc.

No trades
See on Supercharts
Market capitalization
‪712.84 M‬USD
−0.33USD
‪−54.70 M‬USD
‪67.84 M‬
Beta (1Y)
1.25

About Savara, Inc.

CEO
Matthew Pauls
Headquarters
Langhorne
Employees (FY)
37
Founded
1995
ISIN
US8051111016
FIGI
BBG000MS0823
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SVRA is 4.96 USD — it has decreased by 3.88% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Savara, Inc. stocks are traded under the ticker SVRA.
Savara, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Savara, Inc. has a max estimate of 16.00 USD and a min estimate of 6.00 USD.
SVRA earnings for the last quarter are −0.10 USD whereas the estimation was −0.07 USD which accounts for −39.53% surprise. Estimated earnings for the next quarter are −0.10 USD. See more details about Savara, Inc. earnings.
Yes, you can track Savara, Inc. financials in yearly and quarterly reports right on TradingView.
SVRA stock has risen by 5.08% compared to the previous week, the month change is a 5.31% rise, over the last year Savara, Inc. has showed a 181.82% increase.
Like other stocks, SVRA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Savara, Inc. stock right from TradingView charts — choose your broker and connect to your account.
SVRA reached its all-time high on Apr 21, 2006 with the price of 9405.60 USD, and its all-time low was 0.69 USD and was reached on Nov 14, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 37.00 employees. See our rating of the largest employees — is Savara, Inc. on this list?